The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision on Thursday, in part clarifying its precedent on the interpretation of “by others” or “by another” under pre-America Invents Act (AIA) 35 U.S.C. §§ 102(a), (e). The opinion was authored by Judge Linn. Merck Serono appealed two decisions of the Patent Trial and Appeal Board (PTAB) holding claims of Merck’s U.S. Patent Nos. 7,713,947 and 8,377,903 unpatentable in inter partes review (IPR) proceedings brought by Hopewell Pharma Ventures. The Board found the claims unpatentable as obvious over a combination of two prior art references, “Bodor” and “Stelmasiak”.
The post Federal Circuit Clarifies Precedent on Pre-AIA Prior Art ‘By Another’ appeared first on IPWatchdog.com | Patents & Intellectual Property Law.
Recent Posts
- Federal Circuit Clarifies Precedent on Pre-AIA Prior Art ‘By Another’
- Squires Restores PTAB’s RPI Identification Requirement to Exacting Pre-SharkNinja Standard
- Tariffs, Tech Wars, and Patent Turmoil: Navigating IP Strategy in a Rapidly Changing World | IPWatchdog Unleashed
- Life Sciences Masters Panelists Lament Mounting Policy Uncertainty
- Interveners Left Out in the Cold: EPO’s G 2/24 Tightens Rules for Late Parties to Patent Challenges